Individualized Treatment for Immune Thrombocytopenia: Predicting Bleeding Risk

Seminars in Hematology

Volumn 50, Issue SUPPL.1, 2013, Pages

  Neunert, Cindy E ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE ANTIBODY; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING; BRAIN HEMORRHAGE; DISEASE SEVERITY; HEAD INJURY; HEMATURIA; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MUCOSAL BLEEDING; NONHUMAN; PERSONALIZED MEDICINE; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

HEMORRHAGE; HUMANS; INDIVIDUALIZED MEDICINE; PLATELET COUNT; PLATELET TRANSFUSION; RISK FACTORS; THROMBOCYTOPENIA;

EID: 84877677053     PISSN: 00371963     EISSN: 15328686     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2013.03.009     Document Type: Article

References (17)

1. Neunert C., Lim W., Crowther M., et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011, 117:4190-4207.
2. Lehmann H.P., Dambita N., Buchanan G.R., et al. Decision modeling of disagreements: pediatric hematologists' management of idiopathic thrombocytopenic purpura. Med Decis Making 2011, 31:805-815.
3. Butros L.J., Bussel J.B. Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J Pediatr Hematol Oncol 2003, 25(8):660-664.
4. Psaila B., Petrovic A., Page L.K., et al. Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood 2009, 114(23):4777-4783.
5. Elalfy M., Elbarbary N., Khaddah N., et al. Intracranial hemorrhage in acute and chronic childhood immune thrombocytopenic purpura over a ten-year period: an Egyptian multicenter study. Acta Haematol 2010, 123(1):59-63.
6. Choudhary D.R., Naithani R., Mahapatra M., et al. Intracranial hemorrhage in childhood immune thrombocytopenic purpura. Pediatr Blood Cancer 2009, 52(4):529-531.
7. Iyori H., Bessho F., Ookawa H., et al. Intracranial hemorrhage in children with immune thrombocytopenic purpura. Japanese Study Group on childhood ITP. Ann Hematol 2000, 79(12):691-695.
8. Vesely S., Buchanan G.R., Cohen A., et al. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol 2000, 22(1):55-61.
9. Neunert C.E., Buchanan G.R., Imbach P., et al. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood 2008, 112(10):4003-4008.
10. Page L.K., Psaila B., Provan D., et al. The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. Br J Haematol 2007, 138(2):245-248.
11. Olsson A., Andersson P.O., Tengborn L., et al. Serum from patients with chronic idiopathic thrombocytopenic purpura frequently affect the platelet function. Thromb Res 2002, 107(3-4):135-139.
12. Panzer S., Rieger M., Vormittag R., et al. Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia. Eur J Clin Invest 2007, 37(10):814-819.
13. Chu X.X., Hou M., Peng J., et al. Effects of IgG and its F(ab')2 fragments of some patients with idiopathic thrombocytopenic purpura on platelet aggregation. Eur J Haematol 2006, 76(2):153-159.
14. Tantawy A.A., Matter R.M., Hamed A.A., et al. Platelet microparticles in immune thrombocytopenic purpura in pediatrics. Pediatr Hematol Oncol 2010, 27(4):283-296.
15. Jy W., Horstman L.L., Arce M., et al. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992, 119(4):334-345.
16. Goerge T., Ho-Tin-Noe B., Carbo C., et al. Inflammation induces hemorrhage in thrombocytopenia. Blood 2008, 111(10):4958-4964.
17. Kitchens C.S., Pendergast J.F. Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration. Blood 1986, 67(1):203-206.